NCT02933736View on ClinicalTrials.gov

Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

October 17, 2016

Primary Completion Date

March 1, 2023

Study Completion Date

March 31, 2026

Conditions

Glioblastoma MultiformeMeningioma

Interventions

DRUG

Ribociclib

Trial Locations (1)

85013

Barrow Brain and Spine, Phoenix

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

collaborator

Ivy Brain Tumor Center

OTHER

collaborator

Barrow Neurological Institute

OTHER

lead

Nader Sanai

OTHER